Ionis Pharmaceuticals, Inc. 0.0% 01-APR-2026Ionis Pharmaceuticals, Inc. 0.0% 01-APR-2026Ionis Pharmaceuticals, Inc. 0.0% 01-APR-2026

Ionis Pharmaceuticals, Inc. 0.0% 01-APR-2026

No trades
See on Supercharts

Key terms


Outstanding amount
‪632.50 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
0% (Zero)
Coupon frequency
Yield to maturity
3.18%
Maturity date
Apr 1, 2026
Term to maturity
1 year

About Ionis Pharmaceuticals, Inc. 0.0% 01-APR-2026


Sector
Health Technology
Home page
Issue date
Apr 12, 2022
FIGI
BBG00ZXX75N9
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.